The arrival of Tirzepatide at a higher dose represents a important step forward in addressing high blood sugar. Until recently, lower doses were commonly used, but this latest formulation offers the possibility for improved glucose regulation in many patients. Clinicians are evaluating its efficacy and security profile, specifically in patients who